What preoperative medical assessment and clearances are required before extracting multiple maxillary teeth?

Preoperative Clearance for Multiple Maxillary Tooth Extractions

For most patients undergoing multiple maxillary tooth extractions, minimal preoperative clearance is required—this is classified as a low-risk procedure requiring only a focused medical history, physical examination, and selective laboratory testing based on specific clinical indicators rather than routine screening.

Risk Stratification

Multiple tooth extractions are categorized as a high bleeding risk procedure (2-4% risk of major bleeding within 2 days) 1. However, this classification primarily affects anticoagulation management rather than necessitating extensive medical clearance.

Essential Preoperative Assessment Components

Medical History Review

Focus your assessment on conditions that directly impact surgical risk:

• Cardiovascular disease: Active symptoms, recent myocardial infarction (within 6 weeks), recent stent placement (bare-metal within 6 weeks, drug-eluting within 6 months) 2
• Anticoagulation/antiplatelet therapy: Document all agents, dosages, and indications 1, 3, 1
• Bone-modifying agents: History of bisphosphonates, denosumab, or antiangiogenic drugs (critical for MRONJ risk) 4, 2
• Head and neck radiation: Dose to maxilla, timing, and radiation fields 5
• Immunosuppression: Chemotherapy status, HIV, uncontrolled diabetes 2
• Bleeding disorders: Personal or family history of coagulopathy 6
• Liver or kidney disease: Affects medication metabolism and bleeding risk 2

Physical Examination

Do not perform a comprehensive physical examination—focus on:

• Airway assessment (if sedation/anesthesia planned) 7
• Cardiovascular auscultation (if cardiac history present) 7
• Intraoral examination for infection, mucosal lesions 8

Laboratory Testing—Selective, Not Routine

Order tests ONLY when indicated by history or physical findings 6:

• Complete blood count: Only if anemia suspected by history or significant blood loss anticipated 6
• Coagulation studies (PT/INR, PTT): Only for patients on anticoagulants, with bleeding history, or liver disease 9, 6
• Platelet function studies: Only for patients on dual antiplatelet therapy 9
• Electrolytes/creatinine: Only if renal impairment suspected or patient on nephrotoxic medications 6, 2
• Glucose/HbA1c: Only if diabetes poorly controlled or result would change management 6

Routine preoperative testing in healthy patients is NOT indicated and increases costs without improving outcomes 6.

Special Population Management

Anticoagulated Patients

DO NOT routinely discontinue anticoagulation for dental extractions 1, 2:

• Warfarin: Continue therapy; use local hemostatic measures (tranexamic acid mouthwash). Alternative: partial interruption 2-3 days before if INR therapeutic 1
• DOACs: For high-risk bleeding procedures, discontinue apixaban 3 days, rivaroxaban 4 days, dabigatran 4 days before surgery (adjust for renal function) 3
• Antiplatelet agents: Continue aspirin and clopidogrel; use local hemostatic measures 2

Patients on Bone-Modifying Agents

Critical to identify before extraction 4:

• Obtain detailed history of bisphosphonates, denosumab, or antiangiogenic therapy
• Consider alternatives to extraction (root canal, crown) when possible 4
• If extraction necessary: prescribe pentoxifylline 400mg twice daily + tocopherol 1000 IU daily starting 1 week before and continuing 4 weeks after 5
• Prescribe prophylactic antibiotics before and after extraction 5

Post-Radiation Patients

Review radiation treatment plan before finalizing extraction plan 5:

• Determine radiation dose to maxilla at extraction site
• If dose ≥50 Gy: strongly consider alternatives to extraction 5
• If extraction necessary: prescribe prophylactic antibiotics and pentoxifylline/tocopherol regimen 5

Cardiac Conditions

Antibiotic prophylaxis for endocarditis is NOT routinely indicated 10, 2. Prescribe prophylaxis ONLY for:

• Prosthetic cardiac valves
• Previous infective endocarditis
• Unrepaired/palliated cyanotic congenital heart disease
• Completely repaired congenital heart disease with prosthetic material (first 6 months only) 10

Timing considerations:

• Delay elective extractions 6 weeks after myocardial infarction or bare-metal stent 2
• Delay 6 months after drug-eluting stent placement 2

Common Pitfalls to Avoid

1. Ordering routine preoperative labs in healthy patients—this is wasteful and not evidence-based 6
2. Stopping anticoagulation unnecessarily—most dental extractions can be performed safely with continued anticoagulation and local hemostatic measures 1, 2
3. Failing to identify bone-modifying agent history—this significantly increases MRONJ risk 4, 2
4. Prescribing endocarditis prophylaxis too broadly—current guidelines are restrictive 10, 2
5. Not reviewing radiation therapy plans—dose to bone is critical for risk stratification 5

Documentation Requirements

Ensure the dental surgeon receives:

• Current medication list with dosages
• Relevant medical conditions affecting surgical risk
• Recent laboratory values (if obtained for clinical indication)
• Radiation therapy details (if applicable)
• Specific recommendations for anticoagulation management
• Antibiotic prophylaxis recommendations (if indicated)

The key principle: base clearance decisions on patient-specific risk factors identified through targeted history and examination, not on routine screening protocols 7, 6.